Thrombolytic therapy after intraventricular hemorrhage: Do we know enough?

Journal of the Neurological Sciences

Volumn 202, Issue 1-2, 2002, Pages 1-3

  Carhuapoma, J Ricardo ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; PLASMIN; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL MODEL; BLOOD CLOT; BLOOD CLOT LYSIS; BLOOD TOXICITY; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN VENTRICULITIS; CATHETER; CEREBROSPINAL FLUID DRAINAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONTUSION; DISEASE COURSE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRAIN; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; EXTERNAL VENTRICULAR DRAINAGE; FIBRINOLYTIC THERAPY; FLOW KINETICS; HISTOLOGY; HUMAN; HYDROCEPHALUS; INTRACRANIAL PRESSURE; INTRAVENTRICULAR CATHETER; LATENT PERIOD; MORBIDITY; MORTALITY; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SUBARACHNOID HEMORRHAGE; TOXICITY;

CEREBRAL HEMORRHAGE; CEREBRAL VENTRICLES; FIBRINOLYTIC AGENTS; HUMANS; NEURONS;

EID: 0037110421     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00242-3     Document Type: Editorial

References (34)

1. Daverat P., Castel J.P., Dartigues J.F., Orgogozo J.M. Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke. 22:1991;1-6.
2. Adams R.E., Diringer M.N. Response to external ventricular drainage in spontaneous intracerebral hemorrhage with hydrocephalus. Neurology. 50:1998;519-523.
3. Lozier A.P., Sciacca R.R., Romagnoli M.F., Connolly E.S. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 51:2002;170-182.
4. Figueroa B.E., Keep R.F., Betz A.L., Hoff J.T. Plasminogen activators potentiate thrombin-induced brain injury. Stroke. 29:1998;1202-1207.
5. Gong C., Boulis N., Qian J., Turner D.E., Hoff J.T., Keep R.F. Intracerebral hemorrhage-induced neuronal death. Neurosurgery. 48:2001;875-882.
6. Hua Y., Xi G., Keep R.F., Wu J., Jiang Y., Hoff J.T. Plasminogen activator inhibitor-1 induction after experimental intracerebral hemorrhage. J. Cereb. Blood Flow Metab. 22:2002;55-61.
7. Lee K.R., Kawai N., Kim S., Sagher O., Hoff J.T. Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J. Neurosurg. 86:1997;272-278.
8. Lee K.R., Betz A.L., Kim S., Keep R.F., Hoff J.T. The role of the coagulation cascade in brain edema formation after intracerebral hemorrhage. Acta Neurochir. (Wien.). 138:1996;396-400.
9. Lee K.R., Colon G.P., Betz A.L., Keep R.F., Kim S., Hoff J.T. Edema from intracerebral hemorrhage: the role of thrombin. J. Neurosurg. 84:1996;91-96.
10. Lee K.R., Betz A.L., Keep R.F., Chenevert T.L., Kim S., Hoff J.T. Intracerebral infusion of thrombin as a cause of brain edema. J. Neurosurg. 83:1995;1045-1050.
11. Masada T., Hua Y., Xi G., Yang G.Y., Hoff J.T., Keep R.F. Attenuation of intracerebral hemorrhage and thrombin-induced brain edema by overexpression of interleukin-1 receptor antagonist. J. Neurosurg. 95:2001;680-686.
12. Xi G., Keep R.F., Hua Y., Hoff J.T. Thrombin preconditioning, heat shock proteins and thrombin-induced brain edema. Acta Neurochir., Suppl. 76:2000;511-515.
13. Xi G., Wagner K.R., Keep R.F., Hua Y., de Courten-Myers, Broderick J.P.et al. Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke. 29:1998;2580-2586.
14. Xi G., Keep R.F., Hoff J.T. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J. Neurosurg. 89:1998;991-996.
15. Yang G.Y., Betz A.L., Hoff J.T. The effects of blood or plasma clot on brain edema in the rat with intracerebral hemorrhage. Acta Neurochir., Suppl. (Wien.). 60:1994;555-557.
16. Wang Y.-C., Lin C.-C., Lai S.-C., Kuo J.-S. Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship. J. Neurol. Sci. 202:2002;35-41.
17. Pang D., Sclabassi R.J., Horton J.A. Lysis of intraventricular blood clot with urokinase in a canine model: Part 2. In vivo safety study of intraventricular urokinase. Neurosurgery. 19:1986;547-552.
18. Pang D., Sclabassi R.J., Horton J.A. Lysis of intraventricular blood clot with urokinase in a canine model: Part 1. Canine intraventricular blood cast model. Neurosurgery. 19:1986;540-546.
19. Naff N.J., Williams M.A., Rigamonti D., Keyl P.M., Hanley D.F. Blood clot resolution in human cerebrospinal fluid: evidence of first-order kinetics. Neurosurgery. 49:2001;614-619.
20. Akdemir H., Selcuklu A., Pasaoglu A., Oktem I.S., Kavuncu I. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. Neurosurg. Rev. 18:1995;95-100.
21. Coplin W.M., Vinas F.C., Agris J.M., Buciuc R., Michael D.B., Diaz F.G.et al. A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage. Stroke. 29:1998;1573-1579.
22. Findlay J.M., Grace M.G., Weir B.K. Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurgery. 32:1993;941-947.
23. Findlay J.M., Weir B.K., Stollery D.E. Lysis of intraventricular hematoma with tissue plasminogen activator. Case report. J. Neurosurg. 74:1991;803-807.
24. Hudgins R.J., Boydston W.R., Hudgins P.A., Adler S.R. Treatment of intraventricular hemorrhage in the premature infant with urokinase. A preliminary report. Pediatr. Neurosurg. 20:1994;190-197.
25. Mayfrank L., Lippitz B., Groth M., Bertalanffy H., Gilsbach J.M. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage. Acta Neurochir. (Wien.). 122:1993;32-38.
26. Murry K.R., Rhoney D.H., Coplin W.M. Urokinase in the treatment of intraventricular hemorrhage. Ann. Pharmacother. 32:1998;256-258.
27. Naff N.J., Carhuapoma J.R., Williams M.A., Bhardwaj A., Ulatowski J.A., Bederson J.et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30-day survival. Stroke. 31:2000;841-847.
28. Rohde V., Schaller C., Hassler W.E. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage. J. Neurol. Neurosurg. Psychiatry. 58:1995;447-451.
29. Shen P.H., Matsuoka Y., Kawajiri K., Kanai M., Hoda K., Yamamoto S.et al. Treatment of intraventricular hemorrhage using urokinase. Neurol. Med.-Chir. (Tokyo). 30:1990;329-333.
30. Todo T., Usui M., Takakura K. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. J. Neurosurg. 74:1991;81-86.
31. Wang X., Asahi M., Lo E.H. Tissue type plasminogen activator amplifies hemoglobin-induced neurotoxicity in rat neuronal cultures. Neurosci. Lett. 274:1999;79-82.
32. Wang Y.F., Tsirka S.E., Strickland S., Stieg P.E., Soriano S.G., Lipton S.A. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat. Med. 4:1998;228-231.
33. Claassen J., Carhuapoma J.R., Kreiter K.T., Du E.Y., Connolly E.S., Mayer S.A. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke. 33:2002;1225-1232.
34. Kreiter K.T., Copeland D., Bernardini G.L., Bates J.E., Peery S., Claassen J.et al. Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke. 33:2002;200-208.